Sanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Paris, France – May 14, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Kyowa Hakko Kirin Co., Ltd. (Kyowa